This drug researcher just reported earnings and could rally on biotech bounceback, JPMorgan says
- Posted on August 6, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
This drug researcher just reported earnings and could rally on biotech bounceback, JPMorgan says
A resurgence in investments in the biotechnology industry could boost shares of Charles River Laboratories, according to JPMorgan.
